shr-4849
Small moleculeexperimental
Clinical trial activity
4 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Jun 26, 2024 (NCT06443489)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07268040 | Phase 2 | Dec 31, 2025 | Hengrui Therapeutics, Inc. |
| NCT07174583 | Phase 1/Phase 2 (Phase 2) | Oct 14, 2025 | IDEAYA Biosciences |
| NCT07028281 | Phase 2 | Jul 8, 2025 | Suzhou Suncadia Biopharmaceuticals Co., Ltd. |
| NCT06443489 | Phase 1 | Jun 26, 2024 | Suzhou Suncadia Biopharmaceuticals Co., Ltd. |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Suzhou Suncadia Biopharmaceuticals Co., Ltd. | For profit | 2 | 2 | 2 | 2024 |
| Hengrui Therapeutics, Inc. | For profit | 1 | 1 | 1 | 2025 |
| IDEAYA Biosciences | For profit | 1 | 1 | 1 | 2025 |
3 organizations
Page 1 / 1